Intuitive Surgical: AMA Editorial and New Lawsuit a Must Read for Investors … and Patients


  Citron White Bkgd Citron reaffirms its $300 price target on Intuitive Surgical (NYSE:ISRG)

Journal of the AMA study — plus a devastating new lawsuit expose the dark secrets behind the dramatic rise in robotic surgeries….and foretell its end.

This is NOT a story of shorts vs Intuitive Surgical.  

This is a story of the American Medical Association, the Affordable Health Care Act, and tort law vs Intuitive Surgical.

Click here for the entire report.